FTC acts against Genuix “cognitive improvement” supplements

Twelve corporate and four individual defendants have settled Federal Trade Commission charges that they deceptively marketed “cognitive improvement” supplements using sham news websites containing false and unsubstantiated efficacy claims, references to non-existent clinical studies, and fraudulent consumer and celebrity endorsements.

The FTC also alleged that the defendants used affiliate marketers to make deceptive claims about their products, which they sold using different names, including Geniux, Xcel, EVO, and Ion-Z. The settlements ban the defendants from engaging in this conduct.

The FTC's press statement, with links to the complaint and settlements, is here.

Leave a Reply

Your email address will not be published. Required fields are marked *